You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bcl-xL

Showing 1 - 25 of 316
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Herlev (Bcl-Xl_42-CAF09b vaccine)

Completed
  • Prostate Cancer
  • Bcl-Xl_42-CAF09b vaccine
  • Herlev, Denmark
    Herlev Hospital
Jan 10, 2022

Laryngeal Cancer Trial in Ann Arbor (AT-101, Docetaxel, Cisplatin)

Completed
  • Laryngeal Cancer
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 17, 2021

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting
  • Metastatic Endometrial Carcinoma
  • +7 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

Neuroendocrine Tumors Trial in Guangzhou, Shanghai (Pelcitoclax)

Recruiting
  • Neuroendocrine Tumors
  • Guangzhou, Guangdong, China
  • +2 more
Jan 21, 2022

Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

Recruiting
  • Recurrent AL Amyloidosis
  • Refractory AL Amyloidosis
  • Biospecimen Collection
  • +9 more
  • Duarte, California
  • +10 more
Jan 19, 2023

Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

Not yet recruiting
  • Mantle Cell Lymphoma Refractory
  • (no location specified)
May 16, 2023

Solid Tumor, Lymphoma, B-Cell Trial in Guangzhou (LP-118 tablet)

Recruiting
  • Solid Tumor
  • Lymphoma, B-Cell
  • LP-118 tablet
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 15, 2021

Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)

Terminated
  • Small Cell Lung Cancer and Other Solid Tumors
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 24, 2021

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Active, not recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +5 more
  • Sacramento, California
  • +17 more
Aug 2, 2022

Small Cell Lung Cancer Trial in Australia, United States (APG-1252, Paclitaxel)

Terminated
  • Small Cell Lung Cancer
  • Plantation, Florida
  • +7 more
Jul 8, 2022

Immune Thrombocytopenia Trial in New York (Eltrombopag, Romiplostim, healthy controls)

Completed
Has Results
  • Immune Thrombocytopenia
  • New York, New York
    Weill Cornell Medical College
Mar 15, 2019

Leukemia Trial in Boston, Houston (Venetoclax, Standard Chemotherapy)

Recruiting
  • Leukemia
  • Chicago, Illinois
  • +2 more
Oct 3, 2022

Hodgkin Lymphoma Trial in Guadalajara (Pentoxifylline, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Aug 4, 2022

Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)

Not yet recruiting
  • Diabetic Macular Edema
  • +8 more
  • Bakersfield, California
  • +7 more
Aug 23, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Relapsed/Refractory Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Leukemia Trial in France

Recruiting
  • Relapsed/Refractory Acute Lymphoblastic Leukemia
  • T-cell Acute Lymphoblastic Leukemia
    • Amiens, France
    • +30 more
    Apr 14, 2023

    Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia Trial in United States

    Active, not recruiting
    • Recurrent Acute Myeloid Leukemia
    • +3 more
    • Tampa, Florida
    • +5 more
    Nov 18, 2022

    Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston

    Active, not recruiting
    • Metastatic Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Nov 8, 2022

    Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

    Withdrawn
    • Salivary Gland Carcinoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Feb 5, 2022

    Nsclc Trial in Beijing (HL-085, Docetaxel)

    Terminated
    • Nsclc
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Science
    Nov 29, 2021

    AML Trial in Aurora (Venetoclax, CC-486)

    Recruiting
    • AML
    • Aurora, Colorado
    • +1 more
    Apr 4, 2022

    Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)

    Completed
    • Transfusion-dependent Beta-Thalassemia
    • Peshawar, Khyber Pakhtunkhwa, Pakistan
      Blood Care Clinic
    Nov 19, 2023

    Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

    Recruiting
    • Advanced Breast Cancer
    • TQB3909 tablets
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Mar 16, 2023

    Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • +11 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 29, 2021